NM_005101.4:c.471C>T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_005101.4(ISG15):​c.471C>T​(p.Gly157Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00413 in 1,607,432 control chromosomes in the GnomAD database, including 56 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 21 hom., cov: 34)
Exomes 𝑓: 0.0034 ( 35 hom. )

Consequence

ISG15
NM_005101.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -4.92

Publications

7 publications found
Variant links:
Genes affected
ISG15 (HGNC:4053): (ISG15 ubiquitin like modifier) The protein encoded by this gene is a ubiquitin-like protein that is conjugated to intracellular target proteins upon activation by interferon-alpha and interferon-beta. Several functions have been ascribed to the encoded protein, including chemotactic activity towards neutrophils, direction of ligated target proteins to intermediate filaments, cell-to-cell signaling, and antiviral activity during viral infections. While conjugates of this protein have been found to be noncovalently attached to intermediate filaments, this protein is sometimes secreted. [provided by RefSeq, Dec 2012]
ISG15 Gene-Disease associations (from GenCC):
  • Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 1-1014451-C-T is Benign according to our data. Variant chr1-1014451-C-T is described in ClinVar as Benign. ClinVar VariationId is 475281.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.92 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0113 (1715/152278) while in subpopulation AFR AF = 0.0281 (1168/41550). AF 95% confidence interval is 0.0268. There are 21 homozygotes in GnomAd4. There are 870 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 21 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ISG15NM_005101.4 linkc.471C>T p.Gly157Gly synonymous_variant Exon 2 of 2 ENST00000649529.1 NP_005092.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ISG15ENST00000649529.1 linkc.471C>T p.Gly157Gly synonymous_variant Exon 2 of 2 NM_005101.4 ENSP00000496832.1
ISG15ENST00000624697.4 linkc.447C>T p.Gly149Gly synonymous_variant Exon 3 of 3 3 ENSP00000485643.1
ISG15ENST00000624652.1 linkc.*16C>T downstream_gene_variant 3 ENSP00000485313.1

Frequencies

GnomAD3 genomes
AF:
0.0113
AC:
1713
AN:
152160
Hom.:
21
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0282
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00379
Gnomad ASJ
AF:
0.00375
Gnomad EAS
AF:
0.0279
Gnomad SAS
AF:
0.00579
Gnomad FIN
AF:
0.0191
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00115
Gnomad OTH
AF:
0.00813
GnomAD2 exomes
AF:
0.00713
AC:
1754
AN:
246070
AF XY:
0.00664
show subpopulations
Gnomad AFR exome
AF:
0.0280
Gnomad AMR exome
AF:
0.00253
Gnomad ASJ exome
AF:
0.00569
Gnomad EAS exome
AF:
0.0219
Gnomad FIN exome
AF:
0.0200
Gnomad NFE exome
AF:
0.00151
Gnomad OTH exome
AF:
0.00712
GnomAD4 exome
AF:
0.00338
AC:
4917
AN:
1455154
Hom.:
35
Cov.:
37
AF XY:
0.00338
AC XY:
2441
AN XY:
722780
show subpopulations
African (AFR)
AF:
0.0298
AC:
994
AN:
33374
American (AMR)
AF:
0.00287
AC:
128
AN:
44598
Ashkenazi Jewish (ASJ)
AF:
0.00549
AC:
143
AN:
26032
East Asian (EAS)
AF:
0.0250
AC:
987
AN:
39526
South Asian (SAS)
AF:
0.00475
AC:
409
AN:
86130
European-Finnish (FIN)
AF:
0.0183
AC:
953
AN:
52030
Middle Eastern (MID)
AF:
0.00904
AC:
52
AN:
5754
European-Non Finnish (NFE)
AF:
0.000804
AC:
891
AN:
1107572
Other (OTH)
AF:
0.00599
AC:
360
AN:
60138
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
294
587
881
1174
1468
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0113
AC:
1715
AN:
152278
Hom.:
21
Cov.:
34
AF XY:
0.0117
AC XY:
870
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.0281
AC:
1168
AN:
41550
American (AMR)
AF:
0.00379
AC:
58
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00375
AC:
13
AN:
3470
East Asian (EAS)
AF:
0.0278
AC:
144
AN:
5178
South Asian (SAS)
AF:
0.00601
AC:
29
AN:
4828
European-Finnish (FIN)
AF:
0.0191
AC:
203
AN:
10618
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00115
AC:
78
AN:
68008
Other (OTH)
AF:
0.00805
AC:
17
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
87
174
262
349
436
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00498
Hom.:
5
Bravo
AF:
0.0107
EpiCase
AF:
0.00104
EpiControl
AF:
0.00130

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
1.1
DANN
Benign
0.79
PhyloP100
-4.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116002608; hg19: chr1-949831; COSMIC: COSV65106772; COSMIC: COSV65106772; API